World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-7sw5hf
Date of registration: 02/02/2011
Primary sponsor: Luciano Ambrosio Ferreira - Brazil
Public title: LASER ACUPUNCTURE TO TEMPOROMANDIBULAR DISORDER TREATMENT
Scientific title: ADJUVANT LASER ACUPUNCTURE TO OCCLUSAL SPLINT THERAPY: A CONTROLLED TRIAL IN TEMPOROMANDIBULAR DISORDERS PATIENTS
Date of first enrolment: 01/02/2011
Target sample size: 40
Recruitment status: not yet recruiting
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-7sw5hf/
Study type: 
Study design:  Randomized double-blind controlled study.  
Countries of recruitment
Brazil
Contacts
Name: Luciano   Ferreira
Address:  Luis Andrade silveira, 207, Centenário 36045-280 Juiz de Fora Brazil
Telephone: 32 32245637
Email: l3a6f9@yahoo.com.br
Affiliation:  Universidade Federal de Juiz de Fora
Name: Luciano   Ferreira
Address:  Luis Andrade silveira, 207, Centenário 36045-280 Juiz de Fora Brazil
Telephone: 32 32245637
Email: l3a6f9@yahoo.com.br
Affiliation:  Universidade Federal de Juiz de Fora
Key inclusion & exclusion criteria
Inclusion criteria: All subjects participated in this study volunteers by signing the consent
• female subjects;
• aged between 20 and 40;
• irrespective of race, creed or social level;
• presence of a diagnosis of myofascial pain and arthralgia orofacial chronic, persisting for a minimum period of six months;
• minimum intensity of muscle and joint pain of 4.0 points, measured in the Visual Analog Scale (VAS) during the first evaluation.

Exclusion criteria: Subjects with evidence of muscle diseases, rheumatic and joint systemic origin, such as fibromyalgia and rheumatoid arthritis;
• presence of fungal skin changes, hyperplastic, erythematous keloid or continuity in areas related to acupuncture points;
• medical, pharmacological, psychological or physical therapy for temporomandibular disorder (TMD), concomitant therapies introduced in this study;
• pregnants, the possible influence of intrauterine contraction and movement promoted by some acupuncture points such as LI4;
• report or finding of facial trauma as a possible etiology of temporomandibular disorder;
• individuals who have undergone prior treatment with neuromuscular relaxing plate, acupuncture or laser therapy for temporomandibular disorder;
• subject denture wearers an upper or lower;
• individuals with intellectual disability or impairment that would hinder the collection of data.


Age minimum: 20Y
Age maximum: 40Y
Gender: F
Health Condition(s) or Problem(s) studied
Temporomandibular disorder, stress
C05.500.607.221.897
F01.145.126.990
Intervention(s)
In order to reduce the likelihood of systematic errors and allow the use of statistical tests, there will be a simple procedure of random allocation of subjects of this research, which will be distributed in two groups of 20 subjects by drawing lots. Each group will receive a specific treatment modality for TMD defined as follows: 1) Group Therapy - neuromuscular relaxing splint and laser
acupuncture; 2) Control Group - neuromuscular
relaxing relaxing splint and placebo laser. Within each group, the therapeutic will be maintained until the end of the study, the patients being aware voluntary and consistent with the possibility
of receiving one of two proposed therapies
(therapeutic or placebo), were not informed during the processing of their nature therapies. At the end of the study, patients receiving a placebo therapy may undergo therapy for active laser acupuncture if they have persistent symptoms or if they wish. Simple randomisation by using sealed opaque envelope is assumed. In each subject is
assigned a sealed opaque envelope, where
information about the group to which belong will be contained. The number of envelopes for the therapeutic group is equal to the control group,the envelopes being identical with each other. The
draw will be conducted by a person without any link to the survey, which will be in the custody of groups and their participants, the researcher revealed only when the first therapeutic application.
Describe the methods used to generate the sequence in which subjects will be
randomised (sequence generation):
Simple randomisation by using a randomisation table created by computer software (SPSS for Windows 13.0) through computerised sequence generation.

Study Group Intervention:
Low intensity laser acupuncture to temporomandibular disorder treatment, directed to study group. The acupuncture points: S6, SI19, GB20, LI4, L3, SJ3, GB34, Ex-3, low power (50mW) infrared laser, for 90s each, with the obje
Primary Outcome(s)
Physical symptoms evaluation before the intervention and after 1, 2 and 3 months after the intervention. Measurement of muscle and joint pain orofacial by applying the visual analogue scale to palpation stomatognathic sites . At each time, the average intensity of pain experienced by each group will be mensured. The provision of these temporal averages (moments of 0, 1, 2 and 3) will prepare the development of physical symptoms in each group. This evolution will be compared between the groups in order to verify the effectiveness of proposed therapies.

Diagnostic Criteria for Temporomandibular Disorders Research (RDC / TMD, Axis II) to assess the psychosocial impact of emotional distress associated to temporomandibular disorder. Levels of depression and no specific sumptoms (somatization) will be measured through SCL 90R questionary, contained in RDC/DTM. This instrument will be applied before and after institution of therapy in each group. A comparison of symptoms of somatization and depression in the two instances indicate a possible change of these symptoms.
Secondary Outcome(s)
Secondary ID(s)
0253.0.180.000-08
398/2008
ACTRN12611000088943
Source(s) of Monetary Support
Universidade Federal de Juiz de Fora - Brazil
Luciano Ambrosio Ferreira - Brazil
Secondary Sponsor(s)
Amanda Buchara Pereira - Brazil
Marcos Vinicius Queiroz de Paula - Brazil
Universidade Federal de Juiz de Fora - Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history